(2014; 10 pages)
The 16th International Conference of Drug Regulatory Authorities (ICDRA) was held in Rio de Janeiro, Brazil, on 26–29 August 2014. The conference was hosted by the Brazilian Health Surveillance Agency ANVISA, in collaboration with WHO. The recommendations are set out on the following pages.
Government officials and regulators from more than 100 WHO Member States came together at this year’s ICDRA to discuss current challenges and strengthen collaboration. The ICDRA conferences, held every two years, have become a wellestablished forum for regulatory authorities, WHO and interested stakeholders to determine priorities for action in regulation of medical products.
A pre-conference titled “Ensuring Quality and Safety of Biosimilars for Patients Worldwide” was held on 24–25 August at the same venue. The ICDRA pre-conferences are open to participants from regulatory authorities, industry, academia and nongovernmental and international organizations.
WHO. International Conference of Drug Regulatory Authorities [web site]: http://www.who.int/medicines/icdra (includes links to recommendations and presentations of past ICDRA conferences)
16th ICDRA official web site: http://www.icdra.com.br